Latest News
Azenta, Inc.
- Azenta, Inc. Estimates – NASDAQ:AZTA
- Form 4 Azenta Inc: Martin D. Madaus (Interim CEO) For: 22 October
- Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
- Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman
- Azenta Life Sciences introduces cryogenic storage system for fertility clinics
- Azenta (AZTA) Stock Still Looks Undervalued Following A 64% Five Year Fall
- Azenta shutting three Multiomics lab sites under restructuring plan
- Azenta (AZTA) Draws Attention As Automation Story Meets A Pricey Valuation
- Azenta Inc (AZTA) Shares Fall 7.9% -- What GF Score of 83 Tells Investors
- Azenta stock hits 52-week high at 41.84 USD By Investing.com
- Azenta faces class action over CEO resignation and alleged misleading info, stock dropped 12%.
- Azenta faces securities fraud probe after CEO r...
Headlines from the last 30 days, linking to the original publishers. See all market news →